Loading company…
Pepscope provides mass spectrometry analysis to study kinase activity and support drug research.
Pepscope's targeted mass spectrometry technology analyzes biomarkers and mechanisms of action in human cell samples. It provides researchers and pharmaceutical companies with insights into kinome activity for combination therapy, drug repurposing and biomarker research. Founded in 2012, the company is based in Wageningen, Netherlands. In December 2020, it raised EUR 4.3 million from KIKK Capital, Oost NL and Netherlands Enterprise Agency to develop and commercialize QuantaKinome.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in